Best Stocks Under $50
as of the Nov 11, 2026 close
The rule: A share price under $50 and a market value of $2 billion or more.
Ranked by our score out of 100, which blends value, growth, business quality and the price trend.
The top 25 of 190
- 1Pan American SilverPAASGrew sales 37% over the past year, trades at 9.1 times next year's expected earnings and is down 17% this year.$44.86No call yet83No call yet
- 2DLocalDLOGrew sales 57% over the past year, trades at 13.9 times next year's expected earnings and is up 0.4% this year.$13.97No call yet81No call yet
- 3Hecla MiningHLGrew sales 84% over the past year, trades at 17.0 times next year's expected earnings and is down 26% this year.$14.13We'd buy more81We'd buy more
- 4Nu HoldingsNUGrew sales 44% over the past year, trades at 12.3 times next year's expected earnings and is down 26% this year.$12.34We'd buy more79We'd buy more
- 5IndiviorINDVGrew sales 16% over the past year and trades at 7.0 times next year's expected earnings.$36.26We'd buy more78We'd buy more
- 6On HoldingONONGrew sales 17% over the past year, trades at 17.6 times next year's expected earnings and is down 25% this year.$34.72We'd buy more77We'd buy more
- 7Antero ResourcesARGrew sales 19% over the past year, trades at 7.9 times next year's expected earnings and is up 11% this year.$38.19We'd keep it, not buy more77We'd keep it, not buy more
- 8Comstock ResourcesCRKGrew sales 1.0% over the past year, trades at 34.1 times next year's expected earnings and is down 35% this year.$15.13We'd keep it, not buy more76We'd keep it, not buy more
- 9JefferiesJEFGrew sales 18% over the past year, trades at 11.3 times next year's expected earnings and is down 21% this year.$47.81We'd keep it, not buy more76We'd keep it, not buy more
- 10Century AluminumCENXGrew sales 19% over the past year, trades at 2.5 times next year's expected earnings and is down 6.3% this year.$36.71We'd keep it, not buy more76We'd keep it, not buy more
- 11Boston ScientificBSXGrew sales 8.9% over the past year, trades at 13.9 times next year's expected earnings and is down 53% this year.$45.15We'd buy more73We'd buy more
- 12UiPathPATHGrew sales 15% over the past year, trades at 15.1 times next year's expected earnings and is down 20% this year.$13.13We'd buy more73We'd buy more
- 13GFIGrew sales 30% over the past year, trades at 8.2 times next year's expected earnings and is down 9.4% this year.$37.57We'd sell some, not buy more72We'd sell some, not buy more
- 14CelsiusCELHGrew sales 49% over the past year, trades at 22.0 times next year's expected earnings and is down 28% this year.$33.05We'd buy more72We'd buy more
- 15Ally FinancialALLYGrew sales 12% over the past year, trades at 6.5 times next year's expected earnings and is down 13% this year.$38.27We'd buy more72We'd buy more
- 16BGC GroupBGCGrew sales 23% over the past year, trades at 6.9 times next year's expected earnings and is up 27% this year.$11.26We'd buy more72We'd buy more
- 17Gen DigitalGENGrew sales 17% over the past year, trades at 9.5 times next year's expected earnings and is up 14% this year.$30.64We'd buy more72We'd buy more
- 18ZTO Express (Cayman)ZTOGrew sales 17% over the past year, trades at 10.1 times next year's expected earnings and is down 0.5% this year.$20.46No call yet71No call yet
- 19Atlantic Union BanksharesAUBGrew sales 46% over the past year, trades at 9.9 times next year's expected earnings and is up 16% this year.$39.72We'd buy more71We'd buy more
- 20LYFTGrew sales 10% over the past year, trades at 7.8 times next year's expected earnings and is down 11% this year.$17.30We'd sell some, not buy more71We'd sell some, not buy more
- 21Apellis PharmaceuticalsAPLSGrew sales 42% over the past year.$41.03No call yet71No call yet
- 22Catalyst Pharmaceuticals PartnersCPRXGrew sales 12% over the past year and trades at 15.7 times next year's expected earnings.$31.49No call yet71No call yet
- 23SGHCGrew sales 6.1% over the past year, trades at 11.4 times next year's expected earnings and is down 1.2% this year.$11.66We'd keep it, not buy more70We'd keep it, not buy more
- 24AdeiaADEAGrew sales 22% over the past year, trades at 11.8 times next year's expected earnings and is down 0.1% this year.$17.13We'd keep it, not buy more70We'd keep it, not buy more
- 25ASGrew sales 30% over the past year, trades at 21.8 times next year's expected earnings and is down 17% this year.$31.07We'd buy more69We'd buy more
165 more stocks meet the rule today and rank below these.
Related lists
- Best Stocks Under $10By share price
- Best Stocks Under $20By share price
- Best Dividend StocksDividends
- Undervalued StocksValue
- Best Growth StocksGrowth and momentum
- Stocks Near 52-Week Lows That Analysts LikeAnalysts and trading
- Best AI StocksIndustries
- Stocks Insiders Are BuyingInsiders and funds
- All lists →
Sectors on this list
- Technology stocks36 on this list
- Consumer Discretionary stocks32 on this list
- Financials stocks24 on this list
- Health Care stocks20 on this list
- Industrials stocks17 on this list
- Energy stocks15 on this list
- Materials stocks13 on this list
- Real Estate stocks11 on this list
- Communication Services stocks8 on this list
- Consumer Staples stocks7 on this list
- Utilities stocks7 on this list
Prices and company dataas of the Nov 11, 2026 closeUpdated after every trading day